Double blinded randomized controlled trial to reveal the effects of Brazilian propolis intake to rheumatoid arthritis disease activity index
Not Applicable
Completed
- Conditions
- Rheumatoid arthritis
- Registration Number
- JPRN-UMIN000032149
- Lead Sponsor
- Center for Senile Degenerative Disorders (CSDD), Osaka City University Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who can not come to the examination on a regular basis 2) patients with undifferentiated arthritis 3) Patients taking propolis within 4 weeks before consent acquisition 4) Patients with significant obesity (BMI 30 or more) 5) Patients with abnormalities in liver function (AST or ALT more than 3 times higher than normal upper limit) 6) Patients with abnormal renal function (BUN 25 mg / dL or more or serum creatinine 2.0 mg / dL or more) 7) Patients who are pregnant or lactating 8) Patients with food allergy history 9) Others, patients judged by doctors as inappropriate as subjects
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method